This highlights a key regulatory role of PRMT5 in double-strand break repair via the Tip60-EP400 complex in MCC, supporting the concept of synergy between PRMT5 inhibitors and DNA-damaging agents in cancer cells (Gillespie et al, 2024). The gene discussed is PRMT5; the disease is cancer.